Spero Therapeutics (SPRO) Minority Interest (2016 - 2019)

Spero Therapeutics (SPRO) has reported Minority Interest for 4 consecutive years, with $355000.0 the latest figure, recorded in Q3 2019.

• For the quarter ending Q3 2019, Minority Interest changed 0.0% year-over-year to $355000.0; the trailing twelve-month figure through Sep 2019 stood at $355000.0 (changed 0.0% YoY), and the FY2018 full-year result was $355000.0, changed 0.0% from the prior year.
• Minority Interest held at $355000.0 in Q3 2019 per SPRO's latest filing, from $355000.0 in the prior quarter.
• Across five years, Minority Interest topped out at $6.4 million in Q2 2017 and bottomed at -$3.8 million in Q4 2016.
• Historically, Minority Interest has averaged $526636.4 across 4 years, with a median of $355000.0 in 2017.
• The sharpest annual moves came in 2017 and 2018: Minority Interest jumped 109.32% in 2017, then tumbled 94.45% in 2018.
• Over 4 years, Minority Interest stood at -$3.8 million in 2016, then soared by 109.32% to $355000.0 in 2017, then changed by 0.0% to $355000.0 in 2018, then changed by 0.0% to $355000.0 in 2019.
• According to Business Quant data, Minority Interest over the past three periods registered $355000.0, $355000.0, and $355000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.